Form D/A — ZETAGEN THERAPEUTICS, INC.
0001730728-25-000003 · filed Nov 12, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $12,999,998
- Reported amount sold
- $12,908,022
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ZETAGEN THERAPEUTICS, INC.
- CIK
- 1730728
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 841 EAST FAYETTE STREET
SYRACUSE, New York 13210 - Phone
- 315-475-2200
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nikhil Thakur, MD · Executive OfficerAndover, Massachusetts Find on LinkedIn ↗
-
Peter B. Finn · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
Joe C Loy · Executive OfficerWeatherford, Texas Find on LinkedIn ↗
-
Donald Brown · DirectorHopkinton, Massachusetts Find on LinkedIn ↗
-
Ashok Kaveeshwar · DirectorBethesda, Maryland Find on LinkedIn ↗
-
Richard Warburg · DirectorBethesda, Maryland Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗